View Full Version : Lupus Drug BenlystaŽ (belimumab) Priority Review Granted By FDA

08-20-2010, 12:07 PM
BenlystaŽ (belimumab), a potential treatment for systemic lupus erythematosus has been granted a priority review designation by the FDA (Food and Drug Administration, USA), which is granted to medications, that if approved, offer significant treatment advances or provide treatment when no proper therapy exists...

More... (http://mnt.to/f/3HGP)

08-20-2010, 09:19 PM
"The FDA has assigned belimumab a Prescription Drug User Fee Act (PDUFA) target date of December 9, 2010."

Does this mean that it will possibly be available then?